Naloxone Market Trends Increases Steadily in Explore Future Growth by 2026

Increasing launches of new naloxone products in market is expected to be one of the major drivers fueling the global naloxone market growth in the near future.

For instance, in November 2015, Adapt Pharma Inc. received the U.S. Food and Drug Administration’s (FDA’s) approval for its Narcan (naloxone HCl) nasal spray 4mg, indicated for emergency treatment of known or suspected opioid overdose. In June 2016, Sandoz Canada, a division of Novartis AG, launched S.O.S. naloxone hydrochloride injection in Canada. In July 2017, Indivior Inc., a subsidiary of Indivior Plc., received marketing authorization (MA) from the French Regulatory Agency, French National Agency for Medicines and Health Products Safety (ANSM), for Nalscue naloxone hydrochloride nasal spray, indicated for emergency treatment of characterized or suspected opioid overdose, in France.

Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1804

Key players operating in the naloxone market include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

Increasing prevalence of opioid overdosing in key countries such as the U.S. and Canada is expected to increase demand for naloxone and significantly drive global naloxone market’s growth over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention (CDC) in 2018, in the U.S. over 630,000 people died from a drug overdose from 1999 to 2016, and in 2016 around 66% of the 63,600 drug overdose deaths involved an opioid. Furthermore, according to the same source in 2016 the number of deaths involving opioids overdose (which include prescription opioids, heroin, and fentanyl) was five times higher than that in 1999.

Favorable reimbursement scenarios for naloxone products is also expected to boost the adoption of products and fuel the global naloxone market growth. For instance, NARCAN nasal spray, a naloxone intranasal spray provided by ADAPT Pharma Inc., has extensive public and private insurance coverage. ADAPT Pharma Inc., entered into an agreement with major Pharmacy Benefits Managers and insurance companies (including Medicaid) to ensure reasonable and affordable costs to the patient. According to ADAPT Pharma Inc.’s official website around 97% of the U.S. insured lives have access to NARCAN Nasal Spray

Market Dynamics

Increasing launches and approval of new naloxone products in the market is expected to drive the global naloxone market growth over the forecast period. In October, 2016 Health Canada approved Narcan Nasal Spray 4 mg for non-prescription, community use in Canada

Rising prevalence of opioid overdose in key regions such as North America, and Europe is expected to drive demand for naloxone products and drive the naloxone market growth in the near future. For instance, according to the data published by European Monitoring Center for Drugs and Drug Addiction (EMCDDA), in 2016, around 150,943 high-risk opioid users were reported in Germany and around 330,445 were reported in the U.K.

Ask Questions to Expertise @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1804

Furthermore, initiatives by various government and private organizations to increase access of naloxone product among the population is also expected to drive market growth. For instance, in 2015, Kaleo, Inc. partnered with the Clinton Foundation and provided bulk discounts on its EVZIO to various college universities and public safety organizations.

Detailed Segmentation:

Global Naloxone Market, By Strength:
0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml and Others
Global Naloxone Market, By Drug Type:
Intranasal
Intramuscular/Subcutaneous
Intravenous
Global Naloxone Market, By Distribution Channel:
Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1804

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.